Shawn M. Jensen

Also affiliated with Providence Portland Medical Center

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies”.

FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.19.522856

N/A

0.165DataRank · unranked

2 citations

Rom S. Leidner, Shawn M. Jensen, Ryan Meng, Andrew Jones, Carmen Ballesteros‐Merino +9 more

Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3944

N/A

0DataRank · unranked

68 citations

Hiroshi Nagata, Irene Wapnir, Chaitanya R. Acharya, Kaitlin Zablotsky, Bernard A. Fox +18 more

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC

Nature Communications(2022)10.1038/s41467-022-31941-w

N/A

0DataRank · unranked

176 citations

Aoife O’Farrell, Farhoud Faraji, Lauren Clubb, Michael M. Allevato, Shawn M. Jensen +17 more

Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCC

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.01.478744

N/A

0DataRank · unranked

9 citations

Aoife O’Farrell, Farhoud Faraji, Lauren Clubb, Michael M. Allevato, Nana-Ama A.S. Anang +16 more

FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0389

N/A

0DataRank · unranked

31 citations

Lucas Blanchard, Rom S. Leidner, Shawn M. Jensen, Ryan Meng, Andrew Jones +12 more

Data from Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy

(2023)10.1158/1078-0432.c.6531311.v1

N/A

0DataRank · unranked

0 citations

Hiroshi Nagata, Irene Wapnir, Chaitanya R. Acharya, Kaitlin Zablotsky, Bernard A. Fox +18 more

Data from Partial CD4 Depletion Reduces Regulatory T Cells Induced by Multiple Vaccinations and Restores Therapeutic Efficacy

(2023)10.1158/1078-0432.c.6517729

N/A

0DataRank · unranked

0 citations

Shawn M. Jensen, Bernard A. Fox, Michael G. LaCelle

Data from Partial CD4 Depletion Reduces Regulatory T Cells Induced by Multiple Vaccinations and Restores Therapeutic Efficacy

(2023)10.1158/1078-0432.c.6517729.v1

N/A

0DataRank · unranked

0 citations

Shawn M. Jensen, Bernard A. Fox, Michael G. LaCelle

Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000599

N/A

0DataRank · unranked

150 citations

Hrishikesh Pandit, Bethany A Nagy, Dimitris Stellas, Shawn M. Jensen, Jenifer Bear +6 more

Phenotypic and clonal evolution of CD4 T cells in HNSCC during immunotherapy: a case report 3277

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1095

N/A

0DataRank · unranked

0 citations

Tarsem Moudgil, Olivier Fesneau, Noah D. Simons, Venkatesh Rajamanickam, Yoshinobu Koguchi +19 more